YouTube exec says goal was viewer value not addiction

Weather - Sydney 10°C

YouTube exec says goal was viewer value not addiction

ECONOMY 23.02.2026

YouTube exec says goal was viewer value not addiction / Photo: © AFP

A landmark social media addiction trial resumed Monday with a YouTube executive insisting that the Google-owned company's aim was to give people value, not hook them on harmful binge-viewing.

Change text size:

YouTube vice president of engineering Cristos Goodrow was pressed to defend the company's self-styled "big, hairy, audacious goal," set more than a decade ago, to increase viewer time to more than a billion hours a day by 2016.

As he did last week when Meta chief executive Mark Zuckerberg testified in the same Los Angeles court, plaintiff's attorney Mark Lanier told jurors that Goodrow's compensation climbed with his company's share price, meaning he profited personally from ramping up user engagement.

"YouTube is not designed to maximize time," Goodrow replied, as he was shown company documents indicating that viewer engagement was a priority for performance at the platform.

"It's designed to give people the most value..."

As a counterpoint, Lanier had Goodrow detail the addition of features including auto-play for videos and ads, and a version of YouTube designed specifically for children.

The lawyer said these efforts enticed users to a "treadmill of continuous checking" for new content.

The attorney also pointed to internal YouTube documents referencing outside research that found harmful effects from spending too much time watching videos.

The trial is set to last until late March, when the jury will decide whether Meta and YouTube bear responsibility for the mental health problems suffered by Kaley G.M., a 20-year-old California resident who has been a heavy social media user since childhood.

Kaley G.M. started using YouTube at age six, Instagram at nine, and later TikTok and Snapchat.

She is expected to testify this week — perhaps as early as Tuesday, according to her lawyers.

Zuckerberg testified last week that he regretted Meta's slow progress in identifying underage users on Instagram, as the plaintiff's legal team sharply criticized the company for deliberately targeting children.

The trial is the first in a series of lawsuits filed by American families against social media platforms and will determine whether Google and Meta deliberately designed their platforms to encourage compulsive use among young people.

The case is expected to set a standard for resolving thousands of lawsuits that blame social media for fueling an epidemic of depression, anxiety, eating disorders, and suicide.

TikTok and Snapchat, also named in the complaint, reached settlements with the plaintiff before the trial began.

V.Allen--TNT

Featured

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Could gas prices return to 2022 highs on US-Iran war?

European gas prices have more than doubled owing to the US-Iran war, just as Europe needs to replenish its reserves ahead of winter.

Change text size:

The National Times - YouTube exec says goal was viewer value not addiction